Inhibrx Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Sales | 0 | 1,634 | 119 | 30 | 17 |
Gross Profit | N/A | 1,634 | 119 | 30 | 17 |
Operating Expenses | 73,825 | 89,923 | 45,946 | 41,369 | 43,783 |
Operating Income | -73,825 | -88,289 | -45,827 | -41,339 | -43,766 |
Interest Expense | 8,130 | 8,223 | 8,149 | 7,905 | 7,563 |
Other Income | 3,245 | 4,538 | 2,189 | 2,197 | 2,413 |
Pre-tax Income | -78,710 | -91,974 | -51,787 | -47,047 | -48,916 |
Income Tax | N/A | -4 | 2 | 5 | N/A |
Net Income Continuous | -78,710 | -93,604 | -51,789 | -47,052 | -48,916 |
Net Income | $-78,710 | $-93,604 | $-51,789 | $-47,052 | $-48,916 |
EPS Basic Total Ops | -1.44 | -1.82 | -1.10 | -1.08 | -1.12 |
EPS Basic Continuous Ops | -1.44 | -1.82 | -1.10 | -1.08 | -1.12 |
EPS Diluted Total Ops | -1.44 | -1.82 | -1.10 | -1.08 | -1.12 |
EPS Diluted Continuous Ops | -1.44 | -1.82 | -1.10 | -1.08 | -1.12 |
EPS Diluted Before Non-Recurring Items | N/A | -1.73 | -1.10 | -1.08 | -1.12 |
EBITDA(a) | $-72,223 | $-86,744 | $-44,284 | $-39,828 | $-42,275 |